TLN1 contains a cancer-associated cassette exon that alters talin-1 mechanosensitivity.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
01 05 2023
Historique:
received: 06 09 2022
revised: 08 01 2023
accepted: 17 02 2023
entrez: 7 3 2023
pubmed: 8 3 2023
medline: 10 3 2023
Statut: ppublish

Résumé

Talin-1 is the core mechanosensitive adapter protein linking integrins to the cytoskeleton. The TLN1 gene is comprised of 57 exons that encode the 2,541 amino acid TLN1 protein. TLN1 was previously considered to be expressed as a single isoform. However, through differential pre-mRNA splicing analysis, we discovered a cancer-enriched, non-annotated 51-nucleotide exon in TLN1 between exons 17 and 18, which we refer to as exon 17b. TLN1 is comprised of an N-terminal FERM domain, linked to 13 force-dependent switch domains, R1-R13. Inclusion of exon 17b introduces an in-frame insertion of 17 amino acids immediately after Gln665 in the region between R1 and R2 which lowers the force required to open the R1-R2 switches potentially altering downstream mechanotransduction. Biochemical analysis of this isoform revealed enhanced vinculin binding, and cells expressing this variant show altered adhesion dynamics and motility. Finally, we showed that the TGF-β/SMAD3 signaling pathway regulates this isoform switch. Future studies will need to consider the balance of these two TLN1 isoforms.

Identifiants

pubmed: 36880935
pii: 213923
doi: 10.1083/jcb.202209010
pmc: PMC9997659
pii:
doi:

Substances chimiques

Talin 0
Adaptor Proteins, Signal Transducing 0
TLN1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cancer Research UK
ID : DRCRPG-May21\100002
Pays : United Kingdom

Informations de copyright

© 2023 Gallego-Paez et al.

Références

Nat Mater. 2014 Jun;13(6):631-7
pubmed: 24793358
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Cancer. 2020 Feb;1(2):235-248
pubmed: 32613204
Mol Cell. 2016 Nov 3;64(3):549-564
pubmed: 27746021
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Nat Rev Mol Cell Biol. 2013 Aug;14(8):503-17
pubmed: 23860236
Cell Death Differ. 2016 Sep 1;23(9):1483-92
pubmed: 27035620
FEBS J. 2009 Mar;276(6):1610-28
pubmed: 19220457
FEBS Lett. 2018 Jun;592(12):2108-2125
pubmed: 29723415
PLoS Biol. 2018 Jul 20;16(7):e2005599
pubmed: 30028837
EMBO J. 2004 Aug 4;23(15):2942-51
pubmed: 15272303
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Signal Transduct Target Ther. 2021 Jan 8;6(1):8
pubmed: 33414388
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell. 2019 Sep 19;179(1):120-131.e13
pubmed: 31539492
J Cell Biol. 2016 May 9;213(3):371-83
pubmed: 27161398
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Cancer Cell. 2018 Aug 13;34(2):211-224.e6
pubmed: 30078747
J Cell Sci. 2021 Oct 15;134(20):
pubmed: 34708856
Cancer Discov. 2019 Jul;9(7):852-871
pubmed: 31053628
Front Cell Neurosci. 2022 Nov 18;16:1014629
pubmed: 36467609
Biophys J. 2011 Jan 19;100(2):517-23
pubmed: 21244848
J Cell Sci. 2017 Aug 1;130(15):2435-2446
pubmed: 28701514
J Biol Chem. 2005 Nov 4;280(44):37217-24
pubmed: 16135522
Front Bioinform. 2022 Feb 24;2:786898
pubmed: 36304260
Nat Commun. 2016 Jul 07;7:11966
pubmed: 27384267
J Cell Biol. 1998 Aug 24;142(4):1121-33
pubmed: 9722622
Sci Rep. 2014 Apr 09;4:4610
pubmed: 24714394
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Nature. 2020 Jan;577(7792):706-710
pubmed: 31942072
Methods Mol Biol. 2021;2217:115-147
pubmed: 33215380
Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):154-61
pubmed: 25615869
J Biol Chem. 2013 Mar 22;288(12):8238-8249
pubmed: 23389036
Nat Cell Biol. 2015 Dec;17(12):1597-606
pubmed: 26523364
Biochem Biophys Res Commun. 2001 Sep 7;286(5):880-5
pubmed: 11527381
Gene. 2005 Dec 5;362:141-52
pubmed: 16216449
Front Mol Neurosci. 2021 Feb 25;14:592951
pubmed: 33716664
Oncogene. 2022 May;41(21):2932-2944
pubmed: 35437308
Database (Oxford). 2020 Jan 1;2020:
pubmed: 32293014
Cell. 2018 Jan 11;172(1-2):373-386.e10
pubmed: 29224780
Contemp Oncol (Pozn). 2015;19(1A):A68-77
pubmed: 25691825
J Am Chem Soc. 2021 Sep 15;143(36):14726-14737
pubmed: 34463480
PLoS Biol. 2011 Dec;9(12):e1001223
pubmed: 22205879
Nanotechnology. 2017 Oct 13;28(41):414002
pubmed: 28766506
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Nat Methods. 2010 May;7(5):391-3
pubmed: 20383133
Science. 2013 May 24;340(6135):991-4
pubmed: 23704575
J Biol Chem. 2021 Jul;297(1):100837
pubmed: 34118235
J Cell Biol. 2018 Nov 5;217(11):3776-3784
pubmed: 30254032
Nat Rev Clin Oncol. 2021 Jan;18(1):9-34
pubmed: 32710082

Auteurs

Lina M Gallego-Paez (LM)

Biomed X Institute (GmbH) , Heidelberg, Germany.

William J S Edwards (WJS)

School of Biosciences, University of Kent , Canterbury, UK.

Manasa Chanduri (M)

Departments of Internal Medicine (Cardiology) and Yale Cardiovascular Research Center , New Haven, CT, USA.

Yanyu Guo (Y)

Mechanobiology Institute, National University of Singapore , Singapore, Singapore.

Thijs Koorman (T)

Department of Pathology, University Medical Center Utrecht , Utrecht, Netherlands.

Chieh-Yu Lee (CY)

Biomed X Institute (GmbH) , Heidelberg, Germany.

Nina Grexa (N)

Biomed X Institute (GmbH) , Heidelberg, Germany.

Patrick Derksen (P)

Department of Pathology, University Medical Center Utrecht , Utrecht, Netherlands.

Jie Yan (J)

Mechanobiology Institute, National University of Singapore , Singapore, Singapore.
Department of Physics, National University of Singapore , Singapore, Singapore.

Martin A Schwartz (MA)

Departments of Internal Medicine (Cardiology) and Yale Cardiovascular Research Center , New Haven, CT, USA.
Departments of Cell Biology and Biomedical Engineering, Yale School of Medicine , New Haven, CT, USA.

Jan Mauer (J)

Biomed X Institute (GmbH) , Heidelberg, Germany.
Department of Immunology, Novartis Institutes for BioMedical Research, Basel, Switzerland.

Benjamin Thomas Goult (BT)

School of Biosciences, University of Kent , Canterbury, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH